November 14, 2022
  • A Kaiser Health News (KHN) investigation found that private equity’s increasing presence in health care has resulted in higher prices, decreased quality of care, lawsuits, and complaints about care. According to PitchBook, private equity firms invested $206 billion in over 1,400 health care companies last year. KHN found that more than 90 percent of private equity takeovers or investments fall below the $101 million threshold that triggers the Federal Trade Commission to conduct an antitrust review, meaning federal regulators are almost blind to the incursion. Since 2014, companies managed or owned by private equity firms have agreed to pay more than $500 million in fines to settle over 34 lawsuits under the False Claims Act. (Article here)